Research Sweden: RNA messenger vaccine rewrites DNA from

Reading time: 2 minutes

On February 25, 2022, a Swedish scientific study was published that proves for the first time that the messenger RNA from the Pfizer vaccine reaches the liver where it is converted into DNA, rewriting the liver cell nucleus and modifying the genome. It is the first evidence in a study that is being reviewed by several experts at Lund University (Malmö) that reverse transcriptase takes place, through which the RNA in the vaccine reaches the nucleus and rewrites the DNA of the cells.

The research was done in the laboratory on human cells, harvested from the liver – an in vitro study, but the authors say that this may also happen in vivo. This confirms what has been speculated since the summer of last year, namely that the mRNA vaccine can lead to alteration of the human genome, which is particularly serious, and more detailed studies will be done for in vivo behavior.

The findings of Swedish researchers are shocking:

“Our study is the first in vitro study of the effect of COVID-19 BNT162b2 mRNA vaccine on the human liver cell line. We present evidence for the rapid entry of BNT162b2 into cells and the subsequent intracellular reverse transcription of BNT162b2 mRNA into DNA. ”

Lund University was ranked 40th in Times Higher Education (THE), the top of the top international universities in 2021.

Although the study has been published for a week, the information has not been widely publicized, and the research is not at all beneficial to the authors of the messenger RNA vaccine, who have always been accused of hiding essential information about vaccine technology and especially its side effects. following vaccination.

In addition to the viral vector vaccines already on the market, a promising solution for the necessary immunization of the population against the new coronavirus would be the new generation of vaccines, which are in advanced stages of testing. These are based on conventional technologies with attenuated virus or the “subunit” vaccine, based on proteins that trigger an immune response without the virus.